Showing results (941-950 of 1,609) with videos related to

Sort By:
Pageof 161
JAMA Oncology|November 22, 2019
Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney CancerSundeep Agrawal, Naomi B Haas, Mohammadhadi Bagheri, et al.
JAMA Oncology|November 8, 2019
Safety, Tolerability, and Potential Clinical Activity of a Glucocorticoid-Induced TNF Receptor-Related Protein Agonist Alone or in Combination With Nivolumab for Patients With Advanced Solid Tumors: A Phase 1/2a Dose-Escalation and Cohort-Expansion Clinical TrialKimberley M Heinhuis, Matteo Carlino, Markus Joerger, et al.
JAMA Oncology|March 13, 2020
Comparison of Carboplatin Plus Pemetrexed Followed by Maintenance Pemetrexed With Docetaxel Monotherapy in Elderly Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer: A Phase 3 Randomized Clinical TrialIsamu Okamoto, Hiroshi Nokihara, Shogo Nomura, et al.
JAMA Oncology|January 11, 2019
Association of Patient Comorbid Conditions With Cancer Clinical Trial ParticipationJoseph M Unger, Dawn L Hershman, Mark E Fleury, et al.
JAMA Oncology|February 1, 2019
Biospecimens, Research Consent, and Distinguishing Cell Line ResearchKayte Spector-Bagdady, Holly Fernandez Lynch, J Chad Brenner, et al.
JAMA Oncology|November 1, 2019
Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical TrialJulien Edeline, Yann Touchefeu, Boris Guiu, et al.
JAMA Oncology|February 14, 2020
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 TrialRita Nanda, Minetta C Liu, Christina Yau, et al.
JAMA Oncology|February 14, 2020
An Emerging Paradigm for Germline Testing in Pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical Practice: A ReviewMichael Rainone, Isha Singh, Erin E Salo-Mullen, et al.
JAMA Oncology|January 17, 2020
Analysis of Price Transparency via National Cancer Institute-Designated Cancer Centers' Chargemasters for Prostate Cancer Radiation TherapyAnkit Agarwal, Anupriya Dayal, Sheetal M Kircher, et al.
JAMA Oncology|January 17, 2020
Effect of Dasatinib vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical TrialShuhong Shen, Xiaojuan Chen, Jiaoyang Cai, et al.
Pageof 161